Article
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.
Nuclear Medicine Communications
(2014)
Disciplines
Publication Date
January 11, 2014
DOI
10.1097/MNM.0000000000000172
Citation Information
Manuela Matesan, Joseph Rajendran, Oliver W. Press, David G. Maloney, et al.. "90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution." Nuclear Medicine Communications Vol. 35 Iss. 11 (2014) p. 1132 - 1142 Available at: http://works.bepress.com/john-pagel/103/